Patch Test
Sponsors
Allerderm, NYU Langone Health, Chulalongkorn University, Rijnstate Hospital, Siemens Gamesa Renewable Energy Blades, S.A.
Conditions
Allergy
Type IV hypersensitivityContact AllergyContact DermatitisDermatitisDermatitis, Allergic ContactDiabetic FootDrug ReactionTo evaluate the efficacy of drug patch test using 0.9% saline vehicle and comparison with standard vehicles in CADRs.
Drug patch test
Phase 1
Phase 3
Unknown Phase
Cutaneous and Systemic Reactions to Metal Implants
TerminatedNCT02483728
Start: 2014-08-31End: 2018-06-05Updated: 2020-01-14
Drug Patch Tests in Patients With Severe Cutaneous Adverse Reaction to Drugs (SCARs)
NCT03176342
Start: 2016-08-04End: 2017-08-03Target: 30Updated: 2017-06-06
Identification of inflammatory mediator profiles associated with dental devices in order to provide leads in detecting an oral allergic reaction.
Active, not recruitingNL-OMON45591
Start: 2017-05-01Target: 50Updated: 2024-02-28
The Prevalence of Contact Allergies for Wound Dressings In Patients With Diabetic Foot Ulcers (PAID Study)
NCT04085705
Start: 2019-09-17End: 2022-12-31Target: 139Updated: 2021-10-18
Prevalence of Skin Sensitization and Dermatitis Among Epoxy-exposed Workers in the Wind Turbine Industry.
CompletedNCT05891743
Start: 2024-03-08End: 2024-10-16Updated: 2024-11-01